Cognitive Performance in Prodromal Neuronal α-Synuclein Disease
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Importance
Cognitive abnormalities may emerge during prodromal neuronal α-synuclein disease (NSD), but their domain specificity and longitudinal course are uncertain.
Objective
To characterize baseline cognition and longitudinal change in prodromal NSD compared with healthy controls, NSD-negative genetic carriers, and sporadic Parkinson disease (PD).
Design
Longitudinal cohort study using Parkinson’s Precision Medicine Initiative (PPMI) data, with first visits from July 2010 through April 2026 and up to 4 years of follow-up.
Setting
Multicenter cohort.
Participants
Healthy controls (HC; n=244), GBA1 or LRRK2 nonmanifesting carriers without NSD (n=323), prodromal NSD participants recruited through hyposmia or isolated rapid eye movement sleep behavior disorder cohorts (n=1640), and sporadic PD (n=824).
Exposures
NSD status and clinical cohort.
Main Outcomes and Measures
Cognitive summary scores for verbal memory, executive function, processing speed, language, and visuospatial function, and PPMI-defined mild cognitive impairment (MCI). Models adjusted for age, sex, education, and APOE ε4 status.
Results:
Among 3031 participants (mean [SD] age, 66.6 [7.0] years; 1322 female [43.6%]), prodromal NSD participants had lower baseline verbal-memory performance than HC (adjusted difference, −0.20 SD; 95% CI, −0.34 to −0.07; adjusted P = .007); NSD-negative genetic carriers did not differ from HC. No other cognitive domain was lower than HC at baseline or longitudinally. In the primary age-adjusted analysis, verbal-memory trajectory differed from HC over 4 years ( P = .009), whereas in a smaller age-matched sensitivity subset through year 3, it did not ( P = .62); the baseline difference persisted (adjusted difference, −0.28 SD; 95% CI, −0.46 to −0.10; P = .003). Adjusted MCI probability increased from 10.2% to 15.1% in prodromal NSD, compared with 8.4% to 5.0% in HC and 13.4% to 17.7% in PD. The increase was greater than in HC (ratio of annual odds ratios, 1.28; 95% CI, 1.04 to 1.58; adjusted P = .04) but not PD ( P = .62).
Conclusions and Relevance
Prodromal NSD was associated with modestly lower verbal memory and increasing MCI probability relative to HC, without lower performance in other cognitive domains. The baseline verbal-memory difference was robust, whereas the longitudinal trajectory finding was not reproduced in the smaller age-matched sensitivity subset.
Key Points
Question
What cognitive differences characterize prodromal neuronal α-synuclein disease, and how do they change over time?
Findings
In this longitudinal cohort study of 3031 participants, prodromal neuronal α-synuclein disease was associated with lower verbal memory at baseline than healthy controls, while other cognitive domains were not lower. In the primary age-adjusted analysis, the verbal-memory trajectory differed from healthy controls over 4 years; in a smaller age-matched sensitivity subset through year 3, it did not differ significantly.
Meaning
Cognitive involvement in prodromal neuronal α-synuclein disease may be detectable as a modest verbal-memory signal, while longitudinal changes require confirmation.
Article activity feed
-
Cognitive Performance in Prodromal Neuronal α Synuclein Disease #NeuroDegeneration 🧪🧠 https://www.medrxiv.org/content/10.64898/2026.11.05.26367361v1
-